Immunitybio Inc (IBRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -351,472 | -289,514 | -222,240 | -129,666 | -413,645 |
| Depreciation Amortization | 15,525 | 11,660 | 7,709 | 3,777 | 40,141 |
| Accounts receivable | -40,211 | -29,656 | -19,766 | -14,669 | -2,360 |
| Accounts payable and accrued liabilities | -190 | -1,169 | 223 | 6,439 | -3,167 |
| Other Working Capital | -54,329 | -39,921 | -27,589 | -22,035 | -19,422 |
| Other Operating Activity | 125,741 | 114,042 | 96,012 | 70,249 | 7,217 |
| Operating Cash Flow | $-304,936 | $-234,558 | $-165,651 | $-85,905 | $-391,236 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -241,373 | -195,747 | -15,161 | -100 | -140,218 |
| PPE Investments | -3,846 | -2,943 | -2,202 | -1,121 | -6,888 |
| Net Acquisitions | N/A | N/A | N/A | N/A | -1,000 |
| Sale Of Investment | 95,824 | 5,350 | 5,350 | 5,350 | 136,607 |
| Other Investing Activity | -406 | -34 | 0 | 0 | -747 |
| Investing Cash Flow | $-149,801 | $-193,374 | $-12,013 | $4,129 | $-12,246 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 2,884 | N/A | N/A | N/A | N/A |
| Debt Repayment | -1,160 | -16 | -4 | 0 | -64 |
| Common Stock Issued | 400,782 | 347,038 | 173,356 | 220 | 190,203 |
| Other Financing Activity | -2,265 | -1,675 | -1,524 | -1,202 | 91,491 |
| Financing Cash Flow | $400,241 | $345,347 | $171,828 | $-982 | $281,630 |
| Exchange Rate Effect | 15 | 10 | 66 | -10 | -23 |
| Beginning Cash Position | 143,912 | 143,912 | 143,912 | 143,912 | 265,787 |
| End Cash Position | 89,431 | 61,337 | 138,142 | 61,144 | 143,912 |
| Net Cash Flow | $-54,481 | $-82,575 | $-5,770 | $-82,768 | $-121,875 |
| Free Cash Flow | |||||
| Operating Cash Flow | -304,936 | -234,558 | -165,651 | -85,905 | -391,236 |
| Capital Expenditure | -3,846 | -2,943 | -2,202 | -1,121 | -6,888 |
| Free Cash Flow | -308,782 | -237,501 | -167,853 | -87,026 | -398,124 |